In response to chronic IL-6-driven inflammatory cues, the liver enhances gluconeogenesis while promoting adipose lipolysis and skeletal muscle proteolysis, metabolic adaptations that collectively culminate in cancer cachexia. Here, IL6 is linked to cancer.